Chiara Dallagiovanna

No ORCID on file · 4 papers in corpus
observational 2026
Clinical use of recombinant human luteinizing hormone beyond hypogonadotropic hypogonadism: a multicenter descriptive analysis from five Italian fertility centers
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-026-01551-y

BACKGROUND: Recombinant human luteinizing hormone (rLH) was originally introduced to supplement recombinant human follicle-stimulating hormone (rFSH) for controlled ovarian stimulation (COS) in patients with hypogonadotropic hypogonadism. P…

observational 2025
Second child after a live birth achieved with assisted reproductive technology: a comparative analysis between endometriosis and other causes of infertility
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.114096

RESEARCH QUESTION: What is the rate of second children among women affected from endometriosis who conceived their first child through Assisted Reproduction Technologies (ARTs)? Are there differences between endometriosis and other causes o…

observational 2023
Progesterone levels during ovarian stimulation in segmented ART cycles inversely correlate with normalized birthweight of neonates conceived through subsequent frozen-thawed embryo transfer
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-023-02861-5

PURPOSE: To evaluate the association between serum progesterone (P) at the day of ovulation trigger and neonatal birthweight in singletons born after frozen-thawed embryo transfer in segmented ART cycles. METHODS: A retrospective multicent…

observational 2022
Women's quality of sleep and in vitro fertilization success
Scientific reports ·doi:10.1038/s41598-022-22534-0

Women undergoing in vitro fertilization (IVF) are emotionally challenged. Anxiety, depression, and sleep disturbances are common complaints. The impact of these symptoms on IVF outcome is however debated. In this study, we aimed at investig…